摘要
目的:观察丹红注射液联合依达拉奉对急性脑梗死患者血清CRP、LP和FG的影响。方法:选取2013年10月—2014年10月本院诊治的急性脑梗死患者100例,随机分为治疗组和对照组,每组50例。对照组给予血栓通治疗,治疗组给予依达拉奉联合丹红注射液治疗。观察患者CRP、LP、FG水平,以及脑卒中神经功能缺损(NIHSS)评分,采用Bar thel指数(BI)评分法测定日常生活活动能力,对各项指标进行分析比较。结果:两组治疗后CRP、LP、FG水平均有所下降,与本组治疗前比较具有明显差异(P<0.05),治疗组治疗后CRP、LP、FG水平优于对照组(P<0.05);治疗组治疗后NIHSS评分、BI评分均优于对照组(P<0.05)。结论:采丹红注射液联合依达拉奉可显著改善患者血清中CRP、LP和FG水平,减少炎症介质的产生,促进患者神经功能恢复。
Objective： To observe the clinical curative effect of Danhong Injection（ DHI） in combination with edaravone on serum CRP and LP and FG of patients with cerebral infarction. Methods： One hundred patients with cerebral infarction who were treated in our hospital between October of 2013 and October of 2014 were chosen as the research objects,and randomly divided into the treatment group and the control group,with 50 cases in each group. The ones in the control group were given Xueshuantong（ XST） for treatment,while the ones in the treatment group were given DHI in combination with edaravone. Then the two groups’ serum CRP and LP and FG levels,and NIHSS were observed; Daily life activity abilities were measured by using BI. And each index was analyzed and compared. Results： After the treatment,the two groups’ serum CRP and LP and FG levels all decreased（ P 〈0. 05）; There was an obvious difference between before and after the treatment within the same group（ P 〈 0. 05）; After the treatment,the serum CRP and LP and FG levels of the treatment group were all better than those of the control group（ P 〈 0. 05）; After the treatment,NIHSS and BI scores of the treatment group were all better than those of the control group（ P 〈 0. 05）. Conclusion：DHI in combination with edaravone can effectively improve the patients’ serum CRP and LP and FG levels,reduce the production of inflammatory mediators,and promote the recovery of neurological functions.
出处
《河南中医》
2016年第6期1001-1003,共3页
Henan Traditional Chinese Medicine
基金
辽宁省科技厅科技攻关计划项目(编号:2011225020)
关键词
急性脑梗死
丹红注射液
依达拉奉
cerebral infarction（CI）
Danhong Injection（DHI））
edaravone
